OR7L1P

Across TCGA pan-cancer cohorts, OR7L1P RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated OR7L1P data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher OR7L1P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR7L1P expression acts as an unfavorable survival marker, although some lineages such as BRCA show a favorable association.

KIRP, ACC, and GBM are the cancer types where OR7L1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Tertile	All	0.176	0.829	<.001	45	view →
ACC	OS	Tertile	All	0.130	0.631	.009	45	view →
GBM	OS	Tertile	All	0.033	0.416	<.001	36	view →
STAD	DFS	Tertile	IV	0.177	0.539	.002	36	view →
KIRC	DFS	Tertile	IV	0.038	0.632	<.001	30	view →
READ	DFS	Tertile	IV	0.332	0.689	<.001	18	view →
THCA	DFS	Tertile	II,III,IV	0.180	0.793	.008	18	view →
SKCM	OS	Tertile	II,III,IV	0.727	0.844	.009	9	view →
DLBC	OS	Tertile	All	0.613	0.945	.049	9	view →
LGG	OS	Tertile	All	0.177	0.523	.047	6	view →
LUAD	OS	Tertile	II,III,IV	0.612	0.784	.011	6	view →
COAD	OS	Tertile	All	0.652	0.814	.044	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

OR7L1P–KIRP (DFS)

Open the KIRP breakdown →